159 related articles for article (PubMed ID: 10415240)
21. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of magnetic resonance imaging of bone marrow in patients with leukemia.
Wang J; Zhang X; Niu J
J Tongji Med Univ; 2001; 21(3):242-5. PubMed ID: 12539590
[TBL] [Abstract][Full Text] [Related]
23. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients.
Kettelhut BV; Parker RI; Travis WD; Metcalfe DD
Am J Clin Pathol; 1989 May; 91(5):558-62. PubMed ID: 2470248
[TBL] [Abstract][Full Text] [Related]
24. Low-field magnetic resonance imaging of bone marrow in the lumbar spine, pelvis, and femur in the adult dog.
Armbrust LJ; Hoskinson JJ; Biller DS; Wilkerson M
Vet Radiol Ultrasound; 2004; 45(5):393-401. PubMed ID: 15487563
[TBL] [Abstract][Full Text] [Related]
25. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.
Akin C; Schwartz LB; Kitoh T; Obayashi H; Worobec AS; Scott LM; Metcalfe DD
Blood; 2000 Aug; 96(4):1267-73. PubMed ID: 10942367
[TBL] [Abstract][Full Text] [Related]
26. MRI of spinal bone marrow: part 2, T1-weighted imaging-based differential diagnosis.
Hanrahan CJ; Shah LM
AJR Am J Roentgenol; 2011 Dec; 197(6):1309-21. PubMed ID: 22109284
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
28. Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study.
Horny HP; Kaiserling E
Br J Haematol; 1988 Aug; 69(4):449-55. PubMed ID: 3408682
[TBL] [Abstract][Full Text] [Related]
29. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
30. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
[TBL] [Abstract][Full Text] [Related]
31. [Acute myelomonocytic leukemia with mastocytosis in bone marrow].
Natori H; Nakamura E; Tanaka K; Naito K; Egami K; Honda J; Osabe S; Imamura Y; Natori K; Yasuda K
Rinsho Ketsueki; 1990 Feb; 31(2):239-44. PubMed ID: 2329687
[TBL] [Abstract][Full Text] [Related]
32. Comparison of inversion recovery fast spin-echo (FSE) with T2-weighted fat-saturated FSE and T1-weighted MR imaging in bone marrow lesion detection.
Pui MH; Chang SK
Skeletal Radiol; 1996 Feb; 25(2):149-52. PubMed ID: 8848745
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
[TBL] [Abstract][Full Text] [Related]
34. [Systemic congenital mastocytosis with universal skin involvement].
Krahl J; Baldauf P; Stoermer D
Hautarzt; 1999 Dec; 50(12):893-6. PubMed ID: 10663026
[TBL] [Abstract][Full Text] [Related]
35. [Systemic mastocytosis].
Almagro Sanchez M; Fonseca Capdevila E; Sanchez Gil A; Casado Jimenez M; Jimenez Acosta F
Med Cutan Ibero Lat Am; 1988; 16(3):213-8. PubMed ID: 3059090
[TBL] [Abstract][Full Text] [Related]
36. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
37. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
38. Systemic mast cell disease presenting with peripheral blood eosinophilia.
Miranda RN; Esparza AR; Sambandam S; Medeiros LJ
Hum Pathol; 1994 Jul; 25(7):727-30. PubMed ID: 8026833
[TBL] [Abstract][Full Text] [Related]
39. Bone Marrow Expression of Mast Cell Disorders.
Sánchez-Muñoz L; Henriques AF; Alvarez-Twose I; Matito A
Immunol Allergy Clin North Am; 2018 Aug; 38(3):379-395. PubMed ID: 30007458
[TBL] [Abstract][Full Text] [Related]
40. Systemic mastocytosis presenting with a prominent B lymphocyte proliferation in the bone marrow and extensive fibrosis of the spleen.
Neşe N; Cagirgan S; Ertan Y; Sönmez A; Soydan S; Hekimgil M
Dis Markers; 2007; 23(3):167-71. PubMed ID: 17473386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
